Medical Director, Department of Surgical Oncology Melanoma and Skin Center at The University of Texas MD Anderson Cancer Center
Jeffrey E. Gershenwald, M.D., is an endowed and tenured Professor in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center, Houston, TX, and serves as Medical Director of its Melanoma and Skin Center.
In addition to his clinical practice, Dr. Gershenwald’s research focuses on enhancing melanoma care through integrated clinicopathological- and molecular-based prognostic and predictive modeling. He co-leads the MD Anderson Melanoma Moon Shots program, an initiative spanning the melanoma continuum from public policy and prevention research initiatives to reduce ultraviolet radiation (UVR) exposure in youth, to leveraging our understanding of the molecular and immune underpinnings of melanoma to improve treatment options. He is also active in the Global Academic Program.
Dr. Gershenwald is an Executive Committee member of the American Joint Committee on Cancer and Chair of its Melanoma Expert Panel; he leads an international effort developing clinical tools to enhance clinical decision-making. Dr. Gershenwald co-led the NCI Cancer Genome Atlas (TCGA) melanoma project, and has published more than 300 articles in peer-reviewed journals, editorials, invited articles, and book chapters. In recognition of his contributions to melanoma prevention, he was awarded the MD Anderson Faculty Achievement Award in Cancer Prevention and the Society for Melanoma Research Skin Cancer Prevention Leadership Award.